Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Gains from Investment Securities (2016 - 2025)

Assembly Biosciences has reported Gains from Investment Securities over the past 11 years, most recently at $53933.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $53933.0 for Q4 2025, down 97.26% from a year ago — trailing twelve months through Dec 2025 was $53933.0 (down 97.26% YoY), and the annual figure for FY2025 was $53933.0, down 94.28%.
  • Gains from Investment Securities for Q4 2025 was $53933.0 at Assembly Biosciences, down from $225000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ASMB hit a ceiling of $7.4 million in Q1 2021 and a floor of -$3.1 million in Q4 2021.
  • Median Gains from Investment Securities over the past 5 years was $222500.0 (2023), compared with a mean of $757111.1.
  • Biggest five-year swings in Gains from Investment Securities: soared 1939.37% in 2021 and later plummeted 2712.01% in 2023.
  • Assembly Biosciences' Gains from Investment Securities stood at -$3.1 million in 2021, then soared by 76.37% to -$724000.0 in 2022, then skyrocketed by 483.84% to $2.8 million in 2023, then fell by 29.26% to $2.0 million in 2024, then crashed by 97.26% to $53933.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $53933.0 (Q4 2025), $225000.0 (Q3 2025), and $225000.0 (Q2 2025) per Business Quant data.